Bardy Diagnostics IPO

Bardy Diagnostics is the developer of a heart monitor known as Carnation Ambulatory Monitor (CAMâ„¢) that can be worn comfortably and discreetly for up to 14 days.

Register for Details

For more details on financing and valuation for Bardy Diagnostics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Bardy Diagnostics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
2/14/2020 Series B-1 $13MM raised $XXX.XX $XXX.XX
4/16/2019 Series B $35.65MM raised $XXX.XX $XXX.XX
7/16/2018 Series A $35.36MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Bardy Diagnostics

Forge green plus iconForge green minus icon

What is Bardy Diagnostics funding to date?

Bardy Diagnostics has raised $84.02MM with the following series:
$35.36MM raised for Series A,$35.65MM raised for Series B,$13MM raised for Series B-1.
Forge green plus iconForge green minus icon

When was Bardy Diagnostics founded?

Bardy Diagnostics was founded in 2013.
Updated on: Jun 12, 2022